K. Amano

发表

The Japanese Immune Tolerance Induction (J‐ITI) study in haemophilia patients with inhibitor: Outcomes and successful predictors of ITI treatment

S. Ohga, T. Matsushita, K. Nogami, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Genotypic and phenotypic features of Japanese patients with mild to moderate hemophilia A

K. Amano, K. Fukutake, H. Inaba, 2013, International journal of hematology.

Moderation of hemophilia A phenotype by the factor V R506Q mutation.

R. Kaufman, D. Ginsburg, K. Michaelides, 1996, Blood.

Quantitative Assessment of the Effect of Pharmacist Counseling on Decisional Conflict: ─ Analysis in the Patients Infected with Human Immunodeficiency Virus ─@@@―HIV感染症患者を対象とした解析―

Takashi Kawaguchi, Takuhiro Yamaguchi, K. Amano, 2013 .

Coagulation assay discrepancies in Japanese patients with non-severe hemophilia A

S. Nishikawa, S. Nishikawa, K. Amano, 2021, International Journal of Hematology.

Chronic kidney disease is related to femoral neck bone loss among HIV-1-infected patients : a retrospective study

T. Muramatsu, K. Amano, K. Fukutake, 2019 .

Ischaemic events are rare, and the prevalence of hypertension is not high in Japanese adults with haemophilia: First multicentre study in Asia

M. Nojima, T. Matsushita, K. Amano, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Acute alveolar haemorrhage in a patient with haemophilia B

K. Amano, K. Fukutake, I. Seita, 2012, Haemophilia.

Long-term administration of pegylated liposomal doxorubicin at almost twice the recommended lifetime dose in 10 years without cardiotoxicity in a Japanese patient with HIV-associated Kaposi sarcoma.

K. Amano, K. Fukutake, T. Muramatsu, 2020, Journal of Infection and Chemotherapy.

Emicizumab‐mediated haemostatic function in patients with haemophilia A is down‐regulated by activated protein C through inactivation of activated factor V

K. Nogami, K. Amano, M. Shima, 2018, British journal of haematology.

Factor VIII Inhibitor Antibodies with C2 Domain Specificity Are Less inhibitory to Factor VIII Complexed with von Willebrand Factor

K. Amano, K. Fukutake, M. Arai, 1996, Thrombosis and Haemostasis.

Identification and characterization of an adenine to guanine transition within intron 10 of the factor VIII gene as a causative mutation in a patient with mild haemophilia A

K. Amano, K. Fukutake, H. Inaba, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Identification of Missense Mutations in the FVII Gene of Three FVII Deficiencies

K. Amano, K. Fukutake, H. Inaba, 2001 .

[Evaluation of the COBAS ampliprep/COBAS TaqMan system for quantification of human immunodeficiency virus type 1 (HIV-1) RNA by real-time PCR].

S. Oka, K. Amano, K. Fukutake, 2008, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

The use of recombinant activated factor VII in patients with acquired haemophilia.

P. Arkhammar, K. Amano, A. Tiede, 2015, Blood reviews.

Clinical practice guidelines for the diagnosis and management of patients with acquired hemophilia A approved by The Japanese Society on Thrombosis and Hemostasis

Y. Toyama, J. Mimuro, J. Takamatsu, 2011 .

Novel FV mutation (W1920R, FVNara) associated with serious deep vein thrombosis and more potent APC resistance relative to FVLeiden.

Tomoko Matsumoto, K. Nogami, K. Amano, 2014, Blood.

Treatment of acute bleeding in acquired haemophilia A with recombinant activated factor VII: analysis of 10‐year Japanese postmarketing surveillance data

K. Amano, M. Shima, S. Higasa, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

A Phase II clinical trial of a mixture of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics

Y. Ohashi, J. Takamatsu, H. Mugishima, 2013, Haemophilia.

Molecular characterization of 3 factor V mutations, R2174L, V1813M, and a 5-bp deletion, that cause factor V deficiency

K. Amano, K. Fukutake, H. Inaba, 2007 .

IgG antibodies against polyethylene glycol (PEG) in patient with hemophilia A

K. Amano, H. Inaba, E. Kinai, 2021, Japanese Journal of Thrombosis and Hemostasis.

The Molecular Pathology of Hemophilia A

K. Amano, 1998 .

The molecular basis for cross-reacting material-positive hemophilia A due to missense mutations within the A2-domain of factor VIII.

R. Kaufman, H. Kazazian, R. Sarkar, 1998, Blood.

A 3-year consecutive survey on current status of acquired inhibitors against coagulation factors in Japan

J. Takamatsu, A. Shirahata, T. Matsushita, 2008 .

ORIHIME study: real-world treatment patterns and clinical outcomes of 338 patients with acquired hemophilia A from a Japanese administrative database

K. Nogami, K. Amano, Y. Ogawa, 2022, International Journal of Hematology.

A multi-center survey of hospital charges for hemophilia and the related diseases in Japan

K. Amano, M. Shima, S. Higasa, 2006 .

Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial

K. Nogami, M. Taki, K. Amano, 2022, BMJ Open.

Prolonged α-thrombin-related activation and delayed active protein C-associated degradation confer mild phenotype in a patient with severe hemophilia A with F8 p.H118R

K. Amano, H. Inaba, E. Kinai, 2022, International Journal of Hematology.

Sub analysis of Japanese patients with hemophilia B in rIX-FP clinical trial

Koji Yamamoto, T. Matsushita, K. Nogami, 2017 .

The Hemostatic Management by Continuous Infusion of Monoclonal Antibody-Purified Factor VIII Concentrate in the Treatment of Patients with Hemophilia A

S. Yoshida, K. Amano, K. Fukutake, 1996 .

Long‐term safety and efficacy of emicizumab for up to 5.8 years and patients’ perceptions of symptoms and daily life: A phase 1/2 study in patients with severe haemophilia A

T. Matsushita, K. Nogami, M. Taki, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Risk factor for inhibitor development

K. Amano, 2010 .

[Examination of the effect of immunosuppressive therapy on acquired hemophilia A in elderly patients with bloodstream infections].

A. Gotoh, K. Amano, Mitsuru Moriyama, 2022, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

Clinical evaluation of bleeds and response to haemostatic treatment in patients with acquired haemophilia: A global expert consensus statement

P. Giangrande, V. Jiménez‐Yuste, G. Benson, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

In vitro validation of chromogenic substrate assay for evaluation of surrogate FVIII-activity of emicizumab.

S. Nagatoishi, K. Amano, H. Inaba, 2023, Thrombosis research.

Current status of emicizumab using in clinical practice based on medical experience at Tokyo Medical University

K. Amano, Yushi Chikasawa, Tomoko Yamaguchi, 2022, Japanese Journal of Thrombosis and Hemostasis.

Outcome of the Japanese Immune Tolerance Induction (ITI) Registry and Predictors of Successful ITI

S. Ohga, T. Matsushita, K. Nogami, 2015 .

[Matrix metalloproteinase (MMP)-3 is not effective for evaluating hemophilic arthropathy].

K. Amano, K. Fukutake, K. Ogata, 2011, Rinsho byori. The Japanese journal of clinical pathology.

Genetic analysis of carrier status in female members of Japanese hemophilia families

K. Amano, K. Fukutake, H. Inaba, 2021, Journal of thrombosis and haemostasis : JTH.

Safety and blood loss in spinal surgery for haemophiliacs: Case series of Japanese haemophiliacs

K. Endo, K. Amano, E. Kinai, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Plasma‐derived factor VIIa and factor X mixture agent (MC710) prophylaxis in haemophilia B patients with inhibitors

M. Migita, A. Shirahata, K. Nogami, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Early elevation of factor IX level in japanese brothers with Haemophilia B Leyden who are carrying c. ‐35 g > a mutations in the promoter region of F9

K. Amano, K. Fukutake, T. Muramatsu, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

The Molecular Basis for Cross-Reacting Material–Positive Hemophilia A Due to Missense Mutations Within the A2-Domain of Factor VIII

R. Kaufman, H. Kazazian, R. Sarkar, 1998 .

Facteur VIII résistant a l'inactivation

K. Amano, Randal J. Kaufman, Steven W. Pipe, 1997 .

Autoantibody to factor VIII that has less reactivity to factor Vlll/von Willebrand Factor Complex

K. Amano, K. Fukutake, Takashi Suzuki, 1995, American journal of hematology.

The Prevalence of Co-infection with Hepatitis Viruses in Human Immunodeficiency Virus (HIV) Infected Patients in Japan and the Efficacy of Hepatitis B Virus (HBV) /Hepatitis A Virus (HAV) Vaccination

K. Amano, K. Fukutake, M. Ohtaki, 2007 .

Two double heterozygous mutations in the F7 gene show different manifestations

K. Amano, K. Fukutake, Y. Hatta, 2002, British journal of haematology.

Phosphatidylserine Unstabilizes Activated Factor VIII

K. Amano, K. Fukutake, M. Arai, 1998 .

Five Novel and four recurrent point mutations in the antithrombin gene causing venous thrombosis

K. Amano, K. Fukutake, H. Inaba, 2003, International journal of hematology.

Management of a Patient with Factor XI Deficiency in Total Hip Joint Replacement by Plasma Exchange Transfusion

Kengo Yamamoto, K. Amano, K. Fukutake, 1995 .

Comparison in Quantification of Human Immunodeficiency Virus Type 1 RNA Measured by Standard Method (Amplicor HIV Monitor Test Ver.1.0) and Add-in Primer Mix Method

K. Amano, K. Fukutake, H. Inaba, 2000 .

The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs

M. Hayakawa, S. Ishikawa, T. Ohmori, 2022, medRxiv.

A novel synonymous variant in the F8 gene, p.(Leu40=)/c.120C>A, likely causes mild haemophilia A

K. Amano, K. Fukutake, H. Inaba, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Identification of deep intronic individual variants in patients with hemophilia A by next‐generation sequencing of the whole factor VIII gene

K. Amano, K. Fukutake, H. Inaba, 2017, Research and practice in thrombosis and haemostasis.

Fluctuations in Plasma Levels of Thrombomodulin in Patients with DIC

K. Amano, K. Fukutake, H. Inaba, 1992, Thrombosis and Haemostasis.

Features of factor VIII activity measurement in Arg531His mutant detected in patients with mild hemophilia A

Y. Yatomi, K. Amano, K. Fukutake, 2008 .

Combination therapy with von Willebrand factor concentrate plus recombinant factor VIII during cesarean section in a patient with type 3 von Willebrand disease and a low inhibitor titer: a case report

K. Amano, K. Fukutake, E. Kinai, 2022, International Journal of Hematology.

Factor X M402T: a homozygous missense mutation identified as the cause of cross-reacting material-reduced deficiency

K. Amano, K. Fukutake, H. Inaba, 2014, International Journal of Hematology.

An Investigational Dosing Algorithm of Emicizumab for Prophylaxis in Acquired Hemophilia a

K. Yoneyama, K. Nogami, K. Amano, 2020 .

A prospective, multicenter, open-label phase III study of emicizumab prophylaxis in patients with acquired hemophilia A.

K. Yoneyama, K. Nogami, K. Amano, 2022, Journal of thrombosis and haemostasis : JTH.

Adherence to anti-retroviral therapy, decisional conflicts, and health-related quality of life among treatment-naïve individuals living with HIV: a DEARS-J observational study

T. Miyaji, Takuhiro Yamaguchi, K. Amano, 2023, Journal of Pharmaceutical Health Care and Sciences.

Mutation at either Arg336 or Arg562 in Factor VIII Is Insufficient for Complete Resistance to Activated Protein C (APC)-mediated Inactivation: Implications for the APC Resistance Test

R. Kaufman, K. Amano, D. Michnick, 1998, Thrombosis and Haemostasis.

Young age is a key determinant of body weight gain after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in Japanese people living with HIV.

K. Amano, T. Muramatsu, E. Kinai, 2022, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Factor VIII haplotypes of Japanese population show similarity to those of Caucasian populations

K. Amano, K. Fukutake, H. Inaba, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Analysis of Free Factor VIII Antigen in Commercial Factor VIII Concentrates

K. Amano, K. Fukutake, M. Arai, 1997 .

Second-generation integrase strand inhibitors can be effective against elvitegravir-derived multiple integrase gene substitutions.

K. Amano, A. Hachiya, E. Kinai, 2020, AIDS.

Serious hazards of transfusion: evaluating the dangers of a wrong patient autologous salvaged blood in cardiac surgery

P. Barach, Masashi Uramatsu, T. Miki, 2022, Journal of Cardiothoracic Surgery.

Usefulness of a simple self‐administered joint condition assessment sheet to predict the need for orthopaedic intervention in the management of haemophilic arthropathy

Kengo Yamamoto, T. Shishido, K. Amano, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Two cases of acquired factor V inhibitor which were initially diagnosed with congenital deficiency by cross mixing tests

K. Amano, K. Fukutake, H. Inaba, 2018 .

Molecular characterization of 3 factor V mutations, R2174L, V1813M, and a 5-bp deletion, that cause factor V deficiency.

K. Amano, K. Fukutake, H. Inaba, 2007, International journal of hematology.

ANALYSIS OF DISCREPANT ASSAY-DETERMINED ACTIVITY LEVELS OF FACTOR VIII ASSOCIATED WITH R531H MUTATION

Y. Yatomi, K. Amano, K. Fukutake, 2007 .